Skip to main content

Table 2 IMP diagnoses influenced real-world intervention and surveillance decisions that were of benefit to patients (total N = 491)

From: Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort

Initial ICG recommendation Initial IMP diagnosis Patients who had clinical intervention at follow-up in reality Patients who had surveillance at follow-up in realitya
n Surgery rate, % Malignant outcome rate, % n Surveillance rate, % Benign outcome rate, %
Surveillance Low risk (n = 195) 33 17 3 162 83 99
High risk (n = 8) 7 88 57 1 12 100
Surgery Low risk (n = 202) 90 45 9 112 55 99
High risk (n = 86) 76 88 66 10 12 100
  1. aMedian follow-up time 2.9 years (range, 1.9 to 7.7 years)